A new ultra-high-throughput sequencing platform boosts output, speeds turnaround, and improves genome coverage. It reduces costs, broadens clinical applications, and accelerates large-scale genomics ...

Now, a step forward in genetic testing could help doctors look deeper than ever before to predict a patient's future health. In a series of studies published recently in Bone Marrow Transplantation, ...

Cancer is caused by faulty genes, but what also shapes a cancer cell's behavior is how a gene's instructions are trimmed and ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

A genome-wide cfDNA methylation enrichment method (cfMeDIP-seq) enables response monitoring using plasma alone, avoiding ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.

Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.

Oxford Nanopore Technologies plc ( ONTTF) Q4 2025 Earnings Call March 2, 2026 5:45 AM EST Good morning, everyone, and thank you for joining us today. Before we move into the 2025 results presentation, ...

Criss Onan traces the rise and evolution of IGM, the radio automation company founded by Rogan Jones, from the 1960s to the ...

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

Standard inclusions cover a streamlined home page for instant clarity on offerings, targeted pages for services, a simple about area to share the company background, and an effective contact section ...